What are the efficacy and functions of Vigabatrin/vigabatrin, and what are the indications?
Vigabatrin/vigabatrin is an anti-epileptic drug. Its mechanism of action is different from that of targeted drugs, so it cannot be counted as a targeted drug. Targeted drugs usually interfere with disease progression by inhibiting specific targets or gene mutations in tumor cells. The principle of action of Vigabatrin is to inhibit an enzyme called "gamma-aminobutyric acid aminotransferase" (GABA-T), thereby increasing the level of the neurotransmitter GABA, thus enhancing the brain's inhibitory neural signals, slowing down excessive neural activity, and achieving the effect of controlling epileptic seizures. It acts on the nervous system and is not a specific cancer cell or mutation target, so it is not a targeted drug.

Vibatrin is closer to traditional anti-epileptic drugs in that it does not directly target cancer cells or tumors and is not a chemotherapy drug. Chemotherapy drugs mainly treat cancer by directly killing rapidly dividing cancer cells, while Vigabatrin is mainly used to treat epilepsy, especially in patients who are ineffective with some conventional anti-epileptic drugs. It helps control epileptic seizures by enhancing the inhibitory effects of the neurotransmitter GABA. Therefore, Vigabatrin is a neurological drug, not a chemotherapy or targeted drug.
In general, the main function of Vigabatrin is as an anti-epileptic drug, which plays a positive role in the treatment of refractory epilepsy, some childhood epilepsy and other diseases. It reduces the frequency and severity of epileptic seizures by increasing GABA levels in the brain, inhibiting abnormal neural activity. Although its side effects may have an impact on patients' quality of life, clinically, Vigabatrin has provided an effective treatment option for many patients, especially those with epilepsy that cannot be controlled by other drugs. Therefore, Vigabatrin is not a targeted drug or chemotherapy drug, but a therapeutic drug that focuses on the nervous system.
Reference materials:https://www.sabril.net/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)